Jiro Hirosumi Selected Research

Jiro Hirosumi Research Topics

5	Insulin Resistance 07/2006 - 04/2002
3	Obesity 07/2006 - 04/2002
2	Type 2 Diabetes Mellitus (MODY) 01/2017 - 11/2002
2	Body Weight (Weight, Body) 01/2017 - 07/2006
2	Hypertriglyceridemia 10/2005 - 06/2004
1	Hyperglycemia 01/2017
1	Overweight 01/2017
1	Inflammation (Inflammations) 07/2006
1	Lymphoma (Lymphomas) 10/2005
1	Glucose Intolerance 09/2005
1	Liver Diseases (Liver Disease) 07/2003

4	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 04/2002
3	Insulin (Novolin)FDA Link 07/2006 - 11/2002
2	Phosphotransferases (Kinase)IBA 07/2006 - 11/2002
2	Rosiglitazone (Avandia)FDA Link 09/2005 - 06/2004
2	Pioglitazone (Actos)FDA Link 09/2005 - 06/2004
1	ipragliflozinIBA 01/2017
1	Hemoglobins (Hemoglobin)IBA 01/2017
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2017
1	Sodium-Glucose Transport ProteinsIBA 01/2017
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2017
1	Protein Isoforms (Isoforms)IBA 07/2006
1	FR177391IBA 10/2005
1	FructoseIBA 10/2005
1	PPAR-gamma AgonistsIBA 09/2005
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 09/2005
1	PPAR gammaIBA 06/2004
1	Prednisolone (Predate)FDA LinkGeneric 07/2003
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 07/2003
1	Insulin-Like Growth Factor I (IGF-1)IBA 07/2003
1	Insulin ReceptorIBA 11/2002
1	Nonesterified Fatty Acids (NEFA)IBA 11/2002
1	CytokinesIBA 11/2002
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2002

1	Therapeutics 11/2002